₹229.5
(Inclusive of all Taxes)
₹34.4 Cashback (15%)
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
Composition :
CHLORTHALIDONE-6.25MG + TELMISARTAN-40MG
Manufacturer/Marketer :
Ipca Laboratories Ltd
Consume Type :
ORAL
Return Policy :
Not Returnable
Expires on or after :
Drug-Drug Interactions
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with CTD-T 6.25/40 Tablet:
Co-administration of Aliskiren with CTD-T 6.25/40 Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking CTD-T 6.25/40 Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Co-administration of Aliskiren with CTD-T 6.25/40 Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking CTD-T 6.25/40 Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Critical
How does the drug interact with CTD-T 6.25/40 Tablet:
Co-administration of CTD-T 6.25/40 Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking CTD-T 6.25/40 Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
Co-administration of CTD-T 6.25/40 Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking CTD-T 6.25/40 Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
TelmisartanPotassium citrate
Severe
How does the drug interact with CTD-T 6.25/40 Tablet:
Taking Potassium citrate with CTD-T 6.25/40 Tablet together may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Potassium citrate with CTD-T 6.25/40 Tablet together can possibly result in an interaction, it can be taken if a doctor has advised it. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
Taking Potassium citrate with CTD-T 6.25/40 Tablet together may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Potassium citrate with CTD-T 6.25/40 Tablet together can possibly result in an interaction, it can be taken if a doctor has advised it. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
Severe
How does the drug interact with CTD-T 6.25/40 Tablet:
Taking trimethoprim with CTD-T 6.25/40 Tablet may increase potassium levels in the blood.
How to manage the interaction:
Although there is an interaction between CTD-T 6.25/40 Tablet and trimethoprim, they can be taken together if prescribed by a doctor. However, consult a doctor if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, and a weak pulse. Do not discontinue the medications without consulting a doctor.
Taking trimethoprim with CTD-T 6.25/40 Tablet may increase potassium levels in the blood.
How to manage the interaction:
Although there is an interaction between CTD-T 6.25/40 Tablet and trimethoprim, they can be taken together if prescribed by a doctor. However, consult a doctor if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, and a weak pulse. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with CTD-T 6.25/40 Tablet:
Taking perindopril with CTD-T 6.25/40 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, CTD-T 6.25/40 Tablet can be taken with perindopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking perindopril with CTD-T 6.25/40 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, CTD-T 6.25/40 Tablet can be taken with perindopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
TelmisartanPotassium iodide
Severe
How does the drug interact with CTD-T 6.25/40 Tablet:
Taking Potassium Iodide with CTD-T 6.25/40 Tablet can make high levels of potassium in the blood more likely.
How to manage the interaction:
Although taking Potassium iodide and CTD-T 6.25/40 Tablet together can evidently cause an interaction, it can be taken if your doctor has suggested it. Do not stop using any medications without a doctor's advice.
Taking Potassium Iodide with CTD-T 6.25/40 Tablet can make high levels of potassium in the blood more likely.
How to manage the interaction:
Although taking Potassium iodide and CTD-T 6.25/40 Tablet together can evidently cause an interaction, it can be taken if your doctor has suggested it. Do not stop using any medications without a doctor's advice.
Severe
How does the drug interact with CTD-T 6.25/40 Tablet:
Co-administration of amiloride with CTD-T 6.25/40 Tablet may increase potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm).
How to manage the interaction:
Although there is a possible interaction, amiloride may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
Co-administration of amiloride with CTD-T 6.25/40 Tablet may increase potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm).
How to manage the interaction:
Although there is a possible interaction, amiloride may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
How does the drug interact with CTD-T 6.25/40 Tablet:
Taking spironolactone with CTD-T 6.25/40 Tablet may increase potassium levels in the blood.
How to manage the interaction:
Although there is a possible interaction, CTD-T 6.25/40 Tablet can be taken with spironolactone if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking spironolactone with CTD-T 6.25/40 Tablet may increase potassium levels in the blood.
How to manage the interaction:
Although there is a possible interaction, CTD-T 6.25/40 Tablet can be taken with spironolactone if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with CTD-T 6.25/40 Tablet:
Coadministration of enalapril with CTD-T 6.25/40 Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with CTD-T 6.25/40 Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Coadministration of enalapril with CTD-T 6.25/40 Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with CTD-T 6.25/40 Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Severe
How does the drug interact with CTD-T 6.25/40 Tablet:
Taking tizanidine with CTD-T 6.25/40 Tablet may have additive effects in lowering the blood pressure.
How to manage the interaction:
Although there is a possible interaction, CTD-T 6.25/40 Tablet can be taken with tizanidine if prescribed by your doctor. Consult the prescriber if you experience symptoms of low blood pressure, such as headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate. Be cautious when getting up from a sitting or lying position. Do not discontinue the medications without consulting a doctor.
Taking tizanidine with CTD-T 6.25/40 Tablet may have additive effects in lowering the blood pressure.
How to manage the interaction:
Although there is a possible interaction, CTD-T 6.25/40 Tablet can be taken with tizanidine if prescribed by your doctor. Consult the prescriber if you experience symptoms of low blood pressure, such as headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate. Be cautious when getting up from a sitting or lying position. Do not discontinue the medications without consulting a doctor.
Drug-Food Interactions
CHLORTHALIDONE-6.25MG+TELMISARTAN-40MGPotassium rich foods
Moderate
Drug-Food Interactions
Login/Sign Up
CHLORTHALIDONE-6.25MG+TELMISARTAN-40MGPotassium rich foods
Moderate
Common Foods to Avoid:
Lentils, Orange Juice, Oranges, Raisins, Potatoes, Salmon Dried, Spinach, Sweet Potatoes, Tomatoes, Coconut Water, Beans, Beetroot, Broccoli, Bananas, Apricots, Avocado, Yogurt
How to manage the interaction:
Taking CTD-T 6.25/40 Tablet along with potassium-containing salt substitutes or over-the-counter potassium supplements it may lead to high potassium levels in blood. Avoid high potassium rich food while taking CTD-T 6.25/40 Tablet as it can possibly result in an interaction. However, consult a doctor if you experience weakness, irregular heartbeat, confusion and feelings of heaviness in the legs.
Lentils, Orange Juice, Oranges, Raisins, Potatoes, Salmon Dried, Spinach, Sweet Potatoes, Tomatoes, Coconut Water, Beans, Beetroot, Broccoli, Bananas, Apricots, Avocado, Yogurt
How to manage the interaction:
Taking CTD-T 6.25/40 Tablet along with potassium-containing salt substitutes or over-the-counter potassium supplements it may lead to high potassium levels in blood. Avoid high potassium rich food while taking CTD-T 6.25/40 Tablet as it can possibly result in an interaction. However, consult a doctor if you experience weakness, irregular heartbeat, confusion and feelings of heaviness in the legs.
Product Substitutes
Alcohol
Unsafe
You are recommended not to consume alcohol and CTD-T 6.25/40 Tablet to avoid unpleasant side effects like drowsiness, dizziness, and liver damage.
Pregnancy
Unsafe
CTD-T 6.25/40 Tablet is not recommended during pregnancy as it is a category D pregnancy drug. This medicine may cause fetal damage and can affect the unborn baby (fetus).
Breast Feeding
Consult your doctor
CTD-T 6.25/40 Tablet is known to pass breast milk, but its effect on the baby is not known. So, before breastfeeding, let your doctor know about this. Either you need to stop breastfeeding for using CTD-T 6.25/40 Tablet , or you need to stop takingCTD-T 6.25/40 Tablet .
Driving
Unsafe
Drive with caution, CTD-T 6.25/40 Tablet usually causes drowsiness and affects driving ability.
Liver
Caution
CTD-T 6.25/40 Tablet to be taken with caution, especially if you have had a history of liver disease. Your doctor will have to change the dosage depending on your medical condition and your reaction to treatment.
Kidney
Unsafe
CTD-T 6.25/40 Tablet is not recommended in patients with chronic kidney disease (severe renal impairment).
Children
Caution
Efficacy and safety of CTD-T 6.25/40 Tablet have not been established in children. If prescribed, it should be strictly under medical supervision and only if the benefits overweight the harms.
Have a query?
Customers Also Bought
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
